Icosapent Ethyl Reduces Atherogenic Markers in High-Risk Statin-Treated Patients With Stage 3 Chronic Kidney Disease and High Triglycerides

Postgraduate Medicine - United Kingdom
doi 10.1080/00325481.2019.1643633

Related search